Literature DB >> 3233789

A characteristic immunoblotting pattern for Opisthorchiasis sera with metacercarial antigens.

S Tanvanich1, G Doungchawee, S Boonpucknavig, W Thamavit.   

Abstract

The protein compositions of homogenized metacercaria and adult Opisthorchis viverrini were characterized by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). The two different stages of O. viverrini parasite contained several protein components with very similar mobilities on SDS-PAGE gel. The reaction in immunoblots of sera from patients with opisthorchiasis demonstrated antibodies against heterogeneous protein components of metacercariae and adult O. viverrini parasites. Only the components of metacercariae with molecular weights of 190-200 kD, 132 kD and 107 kD reacted specifically with opisthorchiasis sera. This characteristic reaction pattern was not observed in any control sera of normal subjects or those infected with other parasites. Identical reactions were however also recognized in the sera of experimental infected hamsters with metacercariae, but did not occur with adult worm as the antigen for the immunoblotting reaction. This may indicate that these metacercariae-associated protein components have potential diagnostic value for opisthorchiasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3233789      PMCID: PMC1542010     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters.

Authors:  W Thamavit; N Bhamarapravati; S Sahaphong; S Vajrasthira; S Angsubhakorn
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

2.  Hepatic carcinoma with opisthorchiasis.

Authors:  D Sonakul; C Koompirochana; K Chinda; T Stitnimakarn
Journal:  Southeast Asian J Trop Med Public Health       Date:  1978-06       Impact factor: 0.267

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Clinical field trial of praziquantel in opisthorchiasis in Nong Rangya Village, Khon Kaen Province, Thailand.

Authors:  C Viravan; D Bunnag; T Harinasuta; S Upatham; S Kurathong; V Viyanant
Journal:  Southeast Asian J Trop Med Public Health       Date:  1986-03       Impact factor: 0.267

5.  Praziquantel in clonorchiasis and opisthorchiasis.

Authors:  T Löscher; H D Nothdurft; L Prüfer; F von Sonnenburg; W Lang
Journal:  Tropenmed Parasitol       Date:  1981-12

6.  The immunological diagnosis of human opisthorchiasis and the humoral immune response to opisthorchis infection in the hamster.

Authors:  J Janechaiwat; S Tharavanij; S Vajrasthira; W Chaicumpa
Journal:  J Med Assoc Thai       Date:  1980-08

7.  A comparative analysis of various developmental stages of Schistosoma mansoni with respect to their protein composition.

Authors:  A Ruppel; D Cioli
Journal:  Parasitology       Date:  1977-12       Impact factor: 3.234

8.  Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel.

Authors:  D Bunnag; T Harinasuta
Journal:  Southeast Asian J Trop Med Public Health       Date:  1980-12       Impact factor: 0.267

9.  Field trial of praziquantel in human opisthorchiasis in Thailand.

Authors:  S Supanvanich; K Supanvanich; P Pawabut
Journal:  Southeast Asian J Trop Med Public Health       Date:  1981-12       Impact factor: 0.267

10.  Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel.

Authors:  D Bunnag; T Harinasuta
Journal:  Southeast Asian J Trop Med Public Health       Date:  1981-09       Impact factor: 0.267

View more
  1 in total

Review 1.  Opisthorchis viverrini: the carcinogenic human liver fluke.

Authors:  Natthawut Kaewpitoon; Soraya-J Kaewpitoon; Prasit Pengsaa; Banchob Sripa
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.